Skip to main content
Premium Trial:

Request an Annual Quote

Biotage Inks Distribution, R&D Pacts with MultiSynTech

NEW YORK (GenomeWeb News) — Under two new agreements it has struck with the German company MultiSynTech, Biotage will join the peptide synthesis market, the Swedish biotech firm said today.

Through one agreement, Biotage has acquired distribution rights to all of MultiSynTech's robotic peptide synthesis systems.

The companies also will work together on a development project to design and market a microwave-aided peptide synthesis system, with the goal of increasing the yield and speed of the peptide synthesis process. The system will integrate Biotage's microwave technology with MutiSynTech's robotic synthesizer technology, the firms said. Customers for the system will include university and biopharmaceutical research groups and contract labs.

These agreements will allow Biotage, which also has operations in the US, Japan, the UK, and Germany, to offer parallel synthesis and microwave synthesis.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.